 | Merus (NASDAQ:MRUS) Stock Price Up 5.6%
americanbankingnews.com - March 5 at 7:54 PM |
 | Merus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Nasdaq
nasdaq.com - March 5 at 1:28 PM |
 | Merus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release - Yahoo Finance
finance.yahoo.com - March 4 at 5:25 PM |
| Merus N.V. (MRUS) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - March 4 at 5:25 PM |
| Analysts Expect Merus (NASDAQ:MRUS) Will Announce Earnings of -$0.62 Per Share
americanbankingnews.com - March 1 at 9:01 AM |
| Zacks: Brokerages Expect Merus (NASDAQ:MRUS) Will Announce Earnings of -$0.62 Per Share
americanbankingnews.com - March 1 at 8:29 AM |
| Merus (NASDAQ:MRUS) Trading Up 9.8%
americanbankingnews.com - February 26 at 6:46 PM |
| Short Interest in Merus (NASDAQ:MRUS) Rises By 67.8%
americanbankingnews.com - February 14 at 5:58 AM |
 | InvestorNewsBreaks – Merus NV (NASDAQ: MRUS) Secures $138M in Underwritten Public Offering - StreetInsider.com
streetinsider.com - February 4 at 9:20 AM |
 | Merus to Participate in Upcoming Investor Conferences - Yahoo Finance UK
uk.finance.yahoo.com - February 1 at 2:42 PM |
|
| Merus to Participate in Upcoming Investor Conferences
finance.yahoo.com - February 1 at 9:42 AM |
| Merus Announces Pricing of Public Offering of Common Shares - Yahoo Finance
finance.yahoo.com - January 22 at 1:50 PM |
 | Merus prices $120M public offering - Seeking Alpha
seekingalpha.com - January 21 at 12:14 PM |
 | Merus Announces Pricing of Public Offering of Common Shares - GlobeNewswire
globenewswire.com - January 21 at 12:14 PM |
| Form S-3MEF Merus NV - StreetInsider.com
streetinsider.com - January 21 at 7:13 AM |
| Lilly signs cancer drug deal worth up to $1.6 billion
finance.yahoo.com - January 20 at 9:38 AM |
| Merus N.V. Announces Proposed Public Offering of Common Shares - Yahoo Finance
finance.yahoo.com - January 19 at 11:38 PM |
| Form 8-K Merus NV For: Jan 18 - StreetInsider.com
streetinsider.com - January 19 at 6:37 PM |
| Form 424B5 Merus NV - StreetInsider.com
streetinsider.com - January 19 at 6:37 PM |
| Merus down 3% after announcing equity offer - Seeking Alpha
seekingalpha.com - January 19 at 6:37 PM |
 | Why Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today - Benzinga
benzinga.com - January 19 at 6:37 PM |
| Merus N.V. Announces Proposed Public Offering of Common Shares - GlobeNewswire
globenewswire.com - January 19 at 6:37 PM |
 | Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies - PRNewswire
prnewswire.com - January 19 at 6:37 PM |
| Merus N.V. Announces Proposed Public Offering of Common Shares
finance.yahoo.com - January 19 at 6:37 PM |
| Merus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and Japan to Enhance Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the eNRGy Clinical Trial - GlobeNewswire
globenewswire.com - January 13 at 7:00 AM |
| Merus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and Japan to Enhance Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the eNRGy Clinical Trial
finance.yahoo.com - January 13 at 1:56 AM |
| Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium - GlobeNewswire
globenewswire.com - January 12 at 2:22 AM |
| Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium - Yahoo Finance
finance.yahoo.com - January 11 at 9:21 PM |
|
| Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium
benzinga.com - January 11 at 5:33 PM |
| Merus (MRUS) Stock Up on FDA's Fast Track Tag for Zenocutuzumab - Yahoo Finance
finance.yahoo.com - January 11 at 4:17 PM |
 | Merus N.V.: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers
finanznachrichten.de - January 9 at 10:12 PM |
| Health Care Sector Update for 01/08/2021: MRUS,DNLI,SRPT - Nasdaq
nasdaq.com - January 8 at 3:50 PM |
| Mid-Afternoon Market Update: Gold Dips 3.5%; Merus Shares Surge - Benzinga
benzinga.com - January 8 at 3:50 PM |
| U.S. to introduce fraud checks for small business pandemic aid program -sources - Nasdaq
nasdaq.com - January 8 at 10:50 AM |
| Health Care Sector Update for 01/08/2021: BNTX, PFE, MRUS, SRPT, XLV, IBB - Nasdaq
nasdaq.com - January 8 at 10:50 AM |
| After-Hours Stock Movers 01/07: (MRUS) (MICT) (WDFC) Higher; (SRPT) (SLDB) (BNGO) Lower (more...) - StreetInsider.com
streetinsider.com - January 7 at 7:28 PM |
| Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers - GlobeNewswire
globenewswire.com - January 7 at 7:28 PM |
| Merus rises 4% on Incyte stake disclosure - Seeking Alpha
seekingalpha.com - December 29 at 7:34 AM |
| Merus NV SC 13D Dec. 28, 2020 4:08 PM - Seeking Alpha
seekingalpha.com - December 29 at 7:34 AM |
| Merus NV (MRUS) Reports Agreement with Sema4 to Support Merus' Phase 1/2 Clinical Trial of Zenocutuzumab - StreetInsider.com
streetinsider.com - December 18 at 7:26 AM |
| Merus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of Zenocutuzumab - Yahoo Finance
finance.yahoo.com - December 17 at 8:40 AM |
| Merus and Sema4 Enter Into an Agreement to Support Merus’ Phase 1/2 Clinical Trial of Zenocutuzumab
finance.yahoo.com - December 17 at 8:40 AM |
| Is MRUS A Good Stock To Buy Now? - Yahoo Finance
finance.yahoo.com - December 14 at 1:38 PM |
| Is MRUS A Good Stock To Buy Now?
finance.yahoo.com - December 14 at 1:38 PM |
| Tarus Therapeutics Strengthens its Board of Directors with Appointment of Paolo Pucci - Yahoo Finance UK
uk.finance.yahoo.com - December 2 at 7:22 AM |
| MPC Capital's subsidiary Cairn Real Estate completes EUR 120 million capital increase for Gateway Fund - Yahoo Finance UK
uk.finance.yahoo.com - November 16 at 3:05 PM |
| Merus to Present at the Jefferies Virtual London Healthcare Conference - Yahoo Finance
finance.yahoo.com - November 16 at 9:55 AM |
| Merus to Present at the Jefferies Virtual London Healthcare Conference
finance.yahoo.com - November 16 at 9:55 AM |
| Form SC 13G Merus NV Filed by: FEDERATED HERMES, INC. - StreetInsider.com
streetinsider.com - November 10 at 1:21 PM |
| Merus Announces Poster Presentations on MCLA-145 at Society for Immunotherapy of Cancer - GlobeNewswire
globenewswire.com - November 9 at 12:19 PM |
